The plethora of efficacious obesity pharmacotherapies with different mechanisms of action will allow tailored treatment plans based on individuals preference, comorbidities and treatment response
Given the recognized window of opportunity in early PsA, future research should prioritize trials in patients with subclinical joint involvement, arthralgia, or early enthesitis, especially those with coexisting obesity or MetS
The rise in popularity of GLP-1 medications like Ozempic and Wegovy has been driven by their dramatic weight loss results
That makes it a useful option if you want a more joint-friendly way to build strength and conditioning, and many people find they can get a solid session done in 1020 minutes
If you maintained a caloric deficit for six months and still did not reach your goal, document that too
The bulk of these side effects impact the GI system, where GLP-1 RAs work to slow down gastric emptying